Radiology Partners and Mosaic Clinical Technologies petition the FDA for clearer regulatory guidelines on imaging AI vision-language models.
Key Details
- 1Radiology Partners and Mosaic Clinical Technologies have submitted a citizen petition to the FDA.
- 2They seek clarity on FDA regulatory status for commercially available vision-language models in diagnostic imaging.
- 3Concerns are raised about the lack of standards for validating performance, safety, and transparency of such AI models.
- 4Current regulatory ambiguity places responsibility and risk on radiologists and downstream users.
- 5The petition asks the FDA to specify whether fine-tuned models require premarket clearance and clarify compliance duties for all stakeholders.
Why It Matters
Clear regulatory guidelines are crucial for ensuring the safety, effectiveness, and responsible deployment of AI models in diagnostic radiology. Standardized oversight will protect patients while supporting innovation and providing consistency for developers and healthcare organizations.
Source
Radiology Business
Related News
•Radiology Business
GE HealthCare Appoints Chief AI Officer to Lead Imaging Innovation
GE HealthCare has hired Rodolphe Katra as its new global chief AI officer to drive its AI strategy in imaging.
•Radiology Business
FDA Authorizations for Radiology AI Devices Surge 42% Since 2023
FDA-cleared radiology AI devices rose by 42% between 2023 and 2025, now totaling over 1,000 approved tools.
•Radiology Business
Rad Partners Wins $1.29M FDA Grant for AI Radiology Report Evaluation Study
Cognita Imaging, part of Rad Partners, has received a $1.29M FDA grant to develop a new framework using large language models (LLMs) to evaluate AI-generated radiology reports.